FDA Inspection 1267207 — HENRY KANAREK, M.D.
The FDA completed an inspection of HENRY KANAREK, M.D. on Mar 26, 2025 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 26, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Overland Park, KS (United States)
Additional details
Clinical Investigator (CI)